Wedgewood Connect, LLC, formerly registered as Leiter's Compounding, San Jose, CA

Is Wedgewood Connect, LLC, formerly registered as Leiter's Compounding an FDA-registered 503B outsourcing facility?

Yes. FDA’s registered outsourcing facility list, updated Nov 6, 2026, names Wedgewood Connect, LLC, formerly registered as Leiter's Compounding in San Jose, CA, first registered Jan 31, 2014 and most recently registered Nov 25, 2025. FDA lists its last inspection as Jul 3, 2025, with a Form FDA 483 issued; FDA lists the action on that inspection as “Response Letter Issued 12/22/2025; FMD-145 Issued 1/2/2026”.

FDA registers outsourcing facilities under section 503B; state boards of pharmacy issue pharmacy licenses separately. FDA’s list does not say which drugs a facility makes.

Location on FDA’s list
San Jose, CA
Initial registration
Jan 31, 2014
Most recent registration
Nov 25, 2025
Last inspection
Jul 3, 2025
Form 483 issued at last inspection
Yes
Recall after last inspection
No
Action on last inspection
Response Letter Issued 12/22/2025; FMD-145 Issued 1/2/2026
Intends to compound sterile drugs from bulk substances
Yes

FDA inspections and actions on record

No entry for this facility was matched on FDA’s compounding inspections and actions page (current as of Oct 22, 2026). FDA may list it under a different name, and the page covers actions from 2019 on.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

The dashboard does list Wedgewood Connect, LLC, San Jose, CA (FEI 3003434972): same name and state, different city, so not treated as this site.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA links 1 Form 483 PDF for Wedgewood Connect, LLC, formerly registered as Leiter's Compounding, but no observation text is shown, for the reasons below.

Linked 483s whose text is not shown

GLP-1 records in this index

No FDA warning letter or recall report naming a GLP-1 drug in this index, as of Nov 15, 2026, is addressed to this facility’s exact legal name (Wedgewood Connect, LLC, formerly registered as Leiter's Compounding). That is not a finding beyond this index’s search.

The Wedgewood Connect, LLC, formerly registered as Leiter's Compounding pharmacy page answers whether it has had a state board action or FDA letter, from the same FDA lists.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.